| abstract |
The present invention relates to the use of proboscis in nutritional compositions or medicaments for the prevention of treatment of gut-neuromuscular abnormalities. Such abnormalities are, for example, associated with colic in babies, gut-pain or gut discomfort in general. In particular, the invention relates to the prevention or treatment of gut neuromuscular abnormalities after infection. Proboscis may be administered in a living or dead state, and also supernatant of fermentation medium may be directly used to achieve the beneficial effects reported herein. |